COVID-19 virus epidemic is good for NVIDIA graphics cards
How to carry out investment layout in the structural market?
Sina Finance's "Fund Live Room" invited fund managers to interpret
the market on the line.
At present, COVID-19 new crown virus has spread to more than
180 countries around the world, and its global economic impact has surpassed
the financial crisis in 2008, and many production and consumption have to stop.
However, analysts are optimistic about NVIDIA's GPU chips, thinking that this virus
epidemic will benefit NVIDIA.
Needham analyst Rajvindra Gill raised NVIDIA's target share
price to $ 249 yesterday, up 17%, and upgraded its rating from hold to buy.
He believes that the epidemic of COVID-19 new crown virus
will drive the demand for NVIDIA graphics cards, because GPU-based accelerator
cards can accelerate the analysis of the human genome.
In addition, Rajvindra Gill also believes that the epidemic
will accelerate the development of global AI technology, and NVIDIA's GPU is
expected to be a key factor in driving this change.
According to Rajvindra Gill, GPUs for medical applications
will gradually become popular with the popularity of COVID-19.
Although this may sound uncomfortable, GPU-based supercomputing does play a role in combating the COVID-19 virus
NVIDIA also mentioned recently that the team of Professor Wei
Dongqing of Shanghai Jiaotong University used 5 DGX-2 AI supercomputers
developed by NVIDIA to find antiviral drugs, and the screening efficiency was
improved from 2 months to 2 days. And the number of papers published is more
than ten times as before.
NVIDIA said that with the help of ultra-high-performance
computing resources and advanced medical research deep learning software, the
team's drug research process has been greatly accelerated. The simulation
calculations that originally took 1 to 2 months can now be completed. It's done
in 1-2 days.
Conclusion
Not only has the work efficiency been greatly improved,
NVIDIA also emphasizes that the speed of publishing scientific research results
has changed. In the past, Professor Wei published four or five papers every
three years, with a maximum of 10 papers.
Share on Social Media >>
Post a Comment